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Abstract 
 
The results of hip and knee replacement surgery are generally regarded as positive for 
patients.  Nonetheless, they are both major operations and have recognised complications. We 
present a review of relevant claims made to the National Health Service Litigation Authority. 
Between 1995 and 2010 there were 1001 claims to a value of £41.5 million following hip 
replacement surgery and 523 claims to a value of £21 million for knee replacement. The most 
common complaint after hip surgery was related to residual neurological deficit, whereas after 
knee replacement it was related to infection. Vascular complications resulted in the highest 
costs per case in each group. 
 
Although there has been a large increase in the number of operations performed, there has not 
been a corresponding relative increase in litigation. The reasons for litigation have remained 
largely unchanged over time after hip replacement. In the case of knee replacement, although 
there has been a reduction in claims for infection, there has been an increase in claims for 
technical errors. There has also been a rise in claims for non-specified dissatisfaction. This 
information is of value to surgeons and can be used to minimise the potential mismatch 
between patient expectation, informed consent and outcome. 
Introduction 
 
The National Health Service Litigation Authority (NHSLA) was created in 1995 to 
indemnify National Health Service Trusts in England. Initially it was only responsible for 
larger claims, but since 2002 has kept data on all claims made against the NHS. Up to 
March 2010 the NHSLA has handled more than 57 000 claims for negligence of all types, 
of which more than 22 400 were related to surgery (excluding obstetrics and gynaecology), 
at a total cost of £1.82 billion.[[1,2]] In the year 2010/2011 it made payments of more than 
£729 million for clinical negligence.[[3]] The NHSLA estimates that its potential liabilities 
for all clinical negligence are in the region of £16.6 billion.[[3]] This aim of this study was 
to review claims made through the NHSLA relating to hip and knee replacement surgery, 
to explore the reasons for litigation and to explore trends over time. 
Hip and knee replacement surgery produce some of the highest health gains, both in 
terms of improvement in quality of life and in cost-effectiveness.[[4-6]] Both are major 
procedures, however, and are associated with well-recognised morbidity and, rarely, 
mortality.[[7,8]] 
The National Joint Registry for England and Wales reported that > 163 000 hip and 
knee replacement operations were performed in the year 2009/2010, nearly double the 
90 000 operations noted in the first annual report of September 2004. It takes the total 
number of hip and knee replacements to > 900 000 since the registry began collecting data 
in 2003.[[9,10]] 
When total claims for negligence are considered year on year, based on the year of 
incident as opposed to the year in which the claim was made, the number of claims 
recorded by the NHSLA has remained relatively stable. Between 1995 and 2006 the mean 
number of claims per year was 5701 (5190 to 6282), although owing to the varying time 
interval between incident and claim it cannot be determined with any certainty how this 
trend has evolved in recent years.[[1]] There is, however, a general perception that 
litigation for alleged medical negligence is increasing.[[11]] This perception has led to 
concern that surgeons are practising defensively at the expense of best practice.[[11-13]] 
Although previous studies have reviewed the general state of litigation for 
orthopaedics[[14]] within the NHS and others within the private sector,[[15]] it is not clear 
whether in the United Kingdom there is evidence of any trend towards increasing litigation 
associated with hip or knee replacement. 
Materials and Methods 
In 2011, a freedom of information request was made to the NHSLA asking for data about 
all claims involving orthopaedics and trauma, to include year of incident, the year the claim 
was made, the nature of the claim and, where applicable, the costs incurred (defence costs, 
claimant costs and damages paid). Data were provided by NHSLA from the period 1995/96 
to 2009/10. These data were then filtered to include only those cases involving hip and 
knee replacement. Definitions such as ‘hip operation’ or ‘knee operation’ were considered 
ambiguous and therefore excluded from this analysis. The details of each claim were then 
categorised and are summarised in Tables I and II. 
Table I. Causes attributed to claims made for hip replacement surgery 
Cause Description 
Neurological deficit Any nerve damage cited in claim 
Technical errors Claims relating to the technical aspects of the operation such as incorrect 
components/incorrectly inserted, and retained cement 
Local infection  Infection of the surgical site only. (Pneumonia etc. included in miscellaneous) 
Miscellaneous Claims either not Specific or inclusive of a low number of rarer causes of claims 
Leg-length inequality Claims for leg-length inequality 
Peri-operative injury Injuries sustained during the operation, such as fractures, burns, lacerations and 
injuries during transfer 
Pain Any reference made to pain were included in this category in addition to the cause if 
detailed 
Wrong-side surgery Any surgery mistakenly performed on the contralateral side 
DVT/PE Where reference to deep vein thrombosis (DVT) or pulmonary embolus (PE) was 
made in the claim 
Post-operative care This group includes all aspects of post-operative care, such as falls and issues 
surrounding nursing and physiotherapy care as well as post-operative renal failure 
Fatality Where there was death from any cause 
Dislocation All claims citing dislocation 
Vascular complications Any vascular insult including vessel injury and compartment syndrome 
Delay Where there was delay from any cause cited 
3M Claims relating to the 3M total hip replacement 
Prosthetic failure Including ceramic fracture or where a specific allegation of prosthesis failure was 
made 
 
 Table II. Causes attributed to claims made for knee replacement surgery 
Cause Description 
Local infection  Infection of the surgical site only. (Pneumonia etc. included in miscellaneous) 
Technical error – component All allegations relating to the technical aspects of the implant and the operation; 
incorrect implant, wrong size or poor alignment. 
Alleged negligence This term was commonly and specifically used without reference to another 
cause 
Miscellaneous Claims either noon specific or inclusive of a low numbeof rarer causes of claims 
Post-operative care This group includes all aspects of post-operative care, such as falls and issues 
surrounding nursing and physiotherapy care as well as post-operative renal 
failure 
Pain Any reference made to pain were included in this category in addition to the 
cause if detailed 
Technical error – other Technical issues during the operation that did not relate to the components, 
such as cementophytes, retained drains and patella not being resurfaced 
Neurological deficit Any nerve damage cited in claim 
Vascular complications Any vascular insult including vessel injury and compartment syndrome 
Peri-operative injury Injuries sustained during the operation, such as fractures, burns, lacerations and 
injuries during transfer. 
DVT/PE Where reference to deep vein thrombosis (DVT) or pulmonary embolus (PE) was 
made in the claim 
Poor range of movement  
Fatality Where there was death from any cause 
Delay Where there was delay due to any cause cited 
Prosthetic failure Where there was failure of a component, e.g. the modular rotating platform, or 
the whole prosthesis 
Dislocation All claims citing dislocation 
 
Owing to the nature of the descriptions attached to a given claim, no distinction was 
made between the various types of hip and knee replacements. As a claim for negligence 
may arise from cumulative dissatisfaction, many claims attribute more than one cause for 
complaint, meaning that there are more ‘causes’ discussed than individual claims. 
Consequently, an individual claim may appear more than once in the data as each cause is 
included separately. Where either ‘no costs’ or only ‘defence costs’ were incurred, this was 
taken to mean that the case was successfully defended (provided the case was closed). 
Where either claimant’s costs or damages were paid, this was interpreted as the NHS 
having lost the case. The data were then sorted to compare, for each cause of claim, the 
total number of claims closed and the total number of these claims that were paid out. 
The data were divided into two periods, 1995/96 to 2002/03 and 2003/04 to 2009/10 
(the approximate halfway point) to allow analysis of any change in the nature and number 
of claims between the two periods. The second period included both open and closed 
claims. 
Results 
Over the study period a total of 22 500 claims were made to the NHSLA relating to surgery 
(excluding obstetrics and gynaecology), with costs > £1.8 billion. Of these, 8950 (40%) 
involved orthopaedics at a cost of £402 million (22%).  
 Of the orthopaedic claims, 1527 (17%) were related to hip or knee replacement 
surgery. The value of these claims to date exceeds £62 million, or 15.5% of the total 
awards made in relation to orthopaedic surgery. Of the claims, 224 (14.6%) remain ‘open’ 
or unsettled at the time of writing (136 hips and 88 knees). 
Hip replacement surgery accounted for 1001 of the claims, at a current cost of over 
£41.5 million. This corresponds to 11% of orthopaedic claims and 10% of the overall cost. 
After knee replacement surgery 523 claims had been made, at a cost of £21 million, which 
represented 6% of all orthopaedic claims and 5% of the total cost. 
Causes of claims data 
A summary of claims relating to hip replacement surgery is detailed in Table III. A total of 
413 of 1001 claims were paid out. The mean total cost of contested cases that were 
subsequently lost and where damages were paid was £98 000.  
Table III. Summary of claims data for hip replacement surgery (DVT, deep-vein thrombosis; 
PE, pulmonary embolism) 
Cause of claim Total number 
of cases (%) 
 
Cases 
closed 
Percentage 
paid (%)
*
 
Highest cost 
(nearest 
£100)
†
 
Mean cost 
(nearest £100)
‡
 
Neurological deficit 159 (13.9) 138 46    £384 500 £116 800 
Technical error 138 (12.0) 123 68    £814 500 £111 700 
Infection 133 (11.6) 113 46    £639 700 £138 600 
Miscellaneous 124 (10.8) 101 38    £531 600 £107 000 
Leg-length inequality 100 (8.7) 100 44    £595 000   £84 000 
Peri-operative injury   86 (7.5)   68 56    £131 900   £48 200 
Dislocation   78 (6.8)   71 51    £448 300 £105 200 
Post-operative care   71 (6.2)   63 62    £466 900   £59 500 
Delay   59 (5.1)   55 45    £324 300   £39 100 
Pain   49 (4.3)   43 44    £448 300 £111 700 
Fatality   37 (2.4)   31 68    £207 800   £49 300 
DVT/PE   36 (3.1)   32 50    £292 000   £58 300 
Prosthetic failure   36 (3.1)   32 50    £354 800   £81 000 
3M system   34 (3.0)   34   3      £46 600   £46 600 
Vascular   13 (1.1)   10 70 £1 052 500 £375 800 
Wrong site     4 (0.3)     4 75      £24 400   £17 400 
*refers to % of total claims that incurred claimant’s cost and/or damages 
† includes all costs, defence, claimants and damages 
‡ mean cost of contested claims subsequently lost 
 
The highest single cost, at > £1.05 million, arose from a case of vascular injury in 
which the involvement of the vascular surgeons was delayed, resulting in compartment 
syndrome. Although cited as a cause in only 13 (1.1%) of claims, vascular injury resulted 
in the highest mean pay-outs. A further four of the 13 claims resulted in compensation > 
£100 000, one of which was > £1 million. These four claims addressed major vessel injury, 
compartment syndrome, amputation and one death. 
Other causes of litigation that resulted in compensation above the mean of £98 000 
were infection, neurological deficit, technical error, pain and dislocation. A ‘miscellaneous’ 
group included 13 paid claims which cost more than £100 000, 12 of which were non-
specified ‘dissatisfaction’ with outcome. 
Comparable data on claims for knee replacement surgery are summarised in Table IV. 
A total of 218 of 523 claims were paid out, with a mean cost for cases contested and loss of 
£93 000. The highest single cost was for a vascular injury that resulted in compartment 
syndrome and subsequent amputation. Vascular injuries accounted for 4.2% of claims but 
generated the highest mean cost (£232 900). There were ten further claims that resulted in 
payments of more than the mean figure for knee replacements (£93 000). Seven of these 
involved compartment syndrome, amputation or both, and the remaining three cases were 
for vascular injury or ischaemia. 
 Table IV. Summary of claims data for knee replacement surgery (DVT, deep-vein 
thrombosis; PE, pulmonary embolism) 
Cause of claim Total number 
of cases (%) 
 
Cases 
closed 
Percentage 
paid (%)
*
 
Highest cost 
(nearest 
£100)
†
 
Mean cost 
(nearest £100)
‡
 
Infection 95 (16.7) 81 41 £447 700 £138 700 
Tech. error component 63 (11.1) 50 76 £391 600   £70 600 
Alleged negligence 64 (11.2) 47 28 £158 300   £65 100 
Miscellaneous 55 (9.6) 49 46 £246 900   £63 200 
Post-operative care 51 (8.9) 48 65 £395 500   £65 800 
Pain 50 (8.8) 44 39 £286 000   £87 000 
Tech. error other 42 (7.4) 31 61 £111 300   £29 100 
Neurological deficit 36 (6.3) 31 52 £393 500 £123 800 
Vascular 24 (4.2) 22 68 £779 000 £232 900 
Peri-operative injury 21 (3.7) 19 53 £230 200   £56 500 
DVT/PE 20 (3.5) 16 38 £192 200 £115 100 
Poor range of 
movement 
19 (3.3) 18 44 £230 200   £75 400 
Fatality 10 (1.8) 9 79 £106 300   £44 200 
Delay 9 (1.6) 8 63   £61 800   £26 700 
Prosthetic failure 7 (1.2) 5 60 £253 700 £176 800 
Dislocation 4 (0.7) 3 67 £202 800 £123 200 
* refers to % of total claims that incurred claimant’s cost and/or damages 
† includes all costs, defence, claimants and damages 
‡ mean cost of contested claims subsequently lost 
 
Other causes that resulted in mean costs greater than average were prosthesis failure, 
infection, neurological deficit, dislocation, and DVT/PE. 
Trends  
For hip replacements, the total number of claims per annum has changed little between the 
two time periods. There were 575 claims in the period 1995/96 to 2002/03 and 581 
between 2003/04 and 2009/10 (Table V). Although the absolute number of claims after hip 
replacement was relatively stable, there was an increase over the two time periods in the 
proportion of claims for injury resulting in neurological deficit, which is now the 
commonest cause of litigation for hip replacement surgery. 
 Table V. Comparison of data before and after 2002/3 for hip replacements (DVT, deep-vein 
thrombosis; PE, pulmonary embolism) 
Cause of complaint 1995 to 2002/03 2003 to 2009/10 
All causes 575 581 
Technical error   13   11 
Neurological deficit   12   15 
Infection   11   12 
Miscellaneous   10   12 
Leg-length inequality     9     9 
Post-operative care     6     6 
Delay     6     4 
3M hip system     6     0 
Dislocation     6     8 
Peri-operative injury     5   10 
Pain     5     4 
DVT/PE     4       2 
Prosthetic failure     4     2 
Fatality     3     3 
Vascular injury     1     1 
Wrong site     0     1 
 
The time trend data for knee replacement show a 46% increase in the total number of 
claims, from 232 to the end of 2002/03 to 337 in 2009/10 (Table VI).  
Table VI. Comparison of data before and after2002/3 for knee replacements (DVT, deep-vein 
thrombosis; PE, pulmonary embolism) 
Cause of complaint 1995 to 2002/03  2003 to 2009/10 
All causes 232 338 
Infection   20   14 
Miscellaneous   13     8 
Post-operative care   11     8 
Neurological deficit     9     5 
Pain     9         9 
Technical error –component     8   13 
Vascular injury     6     3 
Poor ROM     6     2 
Technical error – other     5   13 
Alleged negligence     5   16 
Peri-operative injury     3     4 
DVT/PE     3     4 
Fatality     2     1 
Dislocation      1     1 
Delay     1     2  
Prosthetic failure     0     2 
 
Within the individual categories there is evidence of considerable change in the cited 
reason for bringing a case. ‘Alleged negligence’ increased from 5% to 16%, ‘technical 
error – component’ and ‘technical error – other’ increased by 5% and 4%, respectively. 
Conversely, the proportion of claims associated with infection dropped from 20% to 14%, 
‘miscellaneous’ fell from 13% to 8%, ‘post-operative care’ from11% to 8%, neurological 
deficit from 9% to 5%, and vascular causes from 6% to 3%. 
Discussion 
Despite an increase in the number of hip replacements being carried out during the study 
period, there has not been a dramatic increase in the overall number of claims, 495 claims 
citing 575 complaints up to the end of 2002/003 and 506 claims citing 581 complaints in 
2009/10. Although there is a lag between event and the initiation of claims, there does not 
appear to have been a disproportional increase in litigation for hip replacement surgery. 
Indeed, considering the increased volume of surgery, in relative terms the number of cases 
of litigation has fallen.  
Claims after knee replacement increased by 45% over the two time periods. Although 
this is a bigger increase than seen with hip replacement surgery, the number of total knee 
replacements carried out since 2004 has nearly doubled. Consequently, this also constitutes 
a relative decrease in litigation. In total knee replacement the causes ‘technical error – 
component’, ‘technical error – other’ and ‘post-operative care’ are among the most cited 
causes in overall claims, and are also among the more significant in claims paid out (76% 
to 61%), a trend similar to that seen after hip replacement surgery. It is striking from the 
time-trend data that the proportion of litigation due to infection has fallen from 20% to 
14% by 2010. This must been seen as encouraging. 
It is difficult to draw clear conclusions from the group of claimants citing ’alleged 
negligence’ owing to a lack of detail. This may be due to the way in which the data were 
recorded, or may simply reflect claims that relate to more general dissatisfaction with the 
outcome of knee replacement surgery. What cannot be ignored, however, is that between 
2002/03 and 2009/10 this group underwent the largest increase in claims. The non-specific 
nature of this type of claim, in which it is difficult to isolate the nature of the complaint and 
therefore the resulting loss, may be the cause of the low rate of pay-out, only some 28% of 
all cases being closed.  
Within this dataset there are limitations in the description that accompanies each claim. 
The NHSLA information is intended primarily for claims management. The data are not 
structured for clinical purposes, and the clinical detail within the claim is limited to the 
major points of the claim. Furthermore, before April 2002 the NHSLA did not specifically 
collect data on cases below a certain level (varying between £10 000 and £50 000), so it is 
not possible to draw specific conclusions about trends before this date. 
One assumption we were required to make in this analysis was the absence of co-
liability. It is possible that there were other unknown and confounding factors whereby a 
patient had a reasonable claim for an NHS operation but the NHSLA was not found to be 
liable. An example of this would be the claims associated with the 3M hip, in which the 
liability for costs was passed to the third party.  
The current analysis also only addresses legal challenges that followed alleged 
negligence, and there are likely to be occasions where clinical negligence has occurred but 
litigation has not been pursued, and conversely, cases where clinical negligence has not 
been proven or admitted but a settlement has been agreed.  
Although the current data provide an overview of the causes of litigation, it has not 
been possible to distinguish between the different types of joint replacement operation 
performed, such as hip resurfacing, unicondylar knee replacement, patellofemoral joint and 
more established total replacements. Further work on the patterns of poor outcome and 
legal intervention associated with specific techniques would be instructive. 
This study shows that over the last decade or so the absolute number of claims made 
against the NHSLA for hip replacement surgery has remained fairly stable, but has 
decreased as a proportion of the total procedures performed. Furthermore, the reasons for 
the claims are consistent and generally well recognised by surgeons.  
There have, however, been changes in the pattern of litigation for knee replacement 
surgery, and although cases of infection have reduced in number, a previously small and 
non-specific category where there is simply ‘alleged negligence’ has notably increased. 
This is of concern for surgeons, as it is difficult to plan against such a non-specific 
allegation and it does not help refine techniques or improve outcomes. 
Of equal concern is that there are three categories (‘technical error – component’, 
‘technical error – other’ and ‘post-operative care’), which appear on nearly a third of the 
claims but are not specifically discussed on the BOA consent form. We suggest that the 
pre-operative consenting process might be refined to draw explicit links between non-
specific features such as pain and the possibility of technical shortcomings in the 
procedure. 
It is encouraging that litigation for infection has diminished after both THR and TKR: 
this may reflect improvement in practice. There remains a large group of patients who sue 
the NHS for poorly specified reasons, but the NHSLA data provide no evidence to suggest 
that orthopaedic surgeons are, within the bounds of the NHS, subject to a more litigious 
culture. 
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